These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 21353143

  • 1. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 2. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD, Hake L, Benjamin AB, Adityanjee A.
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroleptic malignant syndrome--a case report].
    Lanczik M, Fritze J.
    Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
    [Abstract] [Full Text] [Related]

  • 4. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J, García García J, Alda Diez JA, Tous Andreu N.
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L, Jaffe A, Levine J.
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
    Turner M, Eerdekens E, Jacko M, Eerdekens M.
    Int Clin Psychopharmacol; 2004 Jul; 19(4):241-9. PubMed ID: 15201572
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M, Mihaljević-Peles A, Sagud M, Silić A, Mihanović M.
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [Abstract] [Full Text] [Related]

  • 10. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.
    W V Med J; 2002 Dec; 98(2):63-5. PubMed ID: 12048741
    [Abstract] [Full Text] [Related]

  • 12. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
    Kontaxakis VP, Christodoulou GN, Markidis MP, Havaki-Kontaxaki BJ.
    Acta Psychiatr Scand; 1988 Sep; 78(3):396-8. PubMed ID: 3195360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risperidone induced stuttering.
    Yadav DS.
    Gen Hosp Psychiatry; 2010 Sep; 32(5):559.e9-10. PubMed ID: 20851282
    [Abstract] [Full Text] [Related]

  • 16. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 17. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA, Millaud F, Nguyen KA.
    Can J Psychiatry; 2002 Nov 15; 47(9):886. PubMed ID: 12500761
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.
    Pharmacopsychiatry; 2002 May 15; 35(3):119-21. PubMed ID: 12107858
    [Abstract] [Full Text] [Related]

  • 20. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
    Tofler IT, Ahmed B.
    J Clin Psychopharmacol; 2003 Dec 15; 23(6):672-4. PubMed ID: 14624203
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.